A Randomised, Single-centre, Double-blind, Parallelgroup, Multiple Dose Trial Comparing the Within-subject Variability of SIBA and Insulin Glargine With Respect to Pharmacodynamic Response at Steady State Conditions in Subjects With Type 1 Diabetes
Phase of Trial: Phase I
Latest Information Update: 11 Oct 2017
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Novo Nordisk
- 21 Sep 2010 Results presented at the 46th Annual Meeting of the European Association for the Study of Diabetes.
- 30 Oct 2009 Actual end date (October 2009) added as reported by ClinicalTrials.gov.
- 30 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.